Biomay Launches Cas9 mRNA in GMP and RUO Grades
16 Jun 2025 //
PRESS RELEASE
Biomay Launches FDA-Grade CRISPR Cas9 for Sale
09 May 2025 //
PRESS RELEASE
Biomay Gets FDA Nod for Cas9 Nuclease Manufacturing
28 Apr 2025 //
PRESS RELEASE
Biomay Offers AAV Plasmids in GMP & Research Quality
17 Oct 2024 //
PRESS RELEASE
Areterna & Biomay Partner for mRNA CDMO Services
18 Sep 2024 //
PRESS RELEASE
Biomay Supports Approval Of First CRISPR/Cas9-Based Therapy
25 Jan 2024 //
PRESS RELEASE
Biomay Expands GMP Facilities For MRNA And Aseptic Filling Services
07 Oct 2023 //
PRESS RELEASE